VICTORIA, Seychelles, 10 nov. 2024 (GLOBE NEWSWIRE) — Bitget, la première bourse de cryptomonnaies et société Web3, publie la dernière valorisation de son Fonds de protection pour octobre 2024. Ce fonds constitue une protection essentielle pour la bourse et témoigne des efforts continus consentis par Bitget pour sécuriser les actifs

Lantronix offre une connectivité IdO sans fil supérieure grâce à une technologie 5G de pointe Meilleure offre concurrentielle et portefeuille clients élargi à des enseignes prestigieuses IRIVINE, Californie, 08 nov. 2024 (GLOBE NEWSWIRE) — Lantronix Inc. (NASDAQ : LTRX), leader mondial des solutions IdO de calcul et de connectivité, annonce

Bitget Protection Fund Hits $424 Million Average, a 40% Increase from its Initial Commitment VICTORIA, Seychelles, Nov. 08, 2024 (GLOBE NEWSWIRE) — Bitget, the leading cryptocurrency exchange and Web3 company, has released the latest valuation of its Protection Fund for October 2024. The fund, an essential safeguard for the exchange

Agventure raises $9.5 million from AgDevCo to help expand its canola oil and seed processing in Kenya NAIROBI, Kenya and LONDON, Nov. 08, 2024 (GLOBE NEWSWIRE) — Specialist agricultural investor AgDevCo is pleased to announce its latest investment in Kenya, into Agventure, a farmer-owned business that is leading the way

Expands Lantronix’s IoT Wireless Connect Portfolio With Cutting-Edge 5G Technology Strengthens Competitive Offering, Adds New Blue-Chip Customers IRVINE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) — Lantronix Inc. (NASDAQ: LTRX), a global leader in IoT compute and connectivity IoT solutions, today announced that it has signed a definitive agreement to acquire

VICTORIA, Seychelles, 07 nov. 2024 (GLOBE NEWSWIRE) — Bitget, la principale bourse de crypto-monnaie et société Web3, a annoncé la cotation des jetons SWELL sur sa plateforme qui couvre une gamme de produits tels que Launchpool, Poolx et le trading Spot. Cette cotation permet aux utilisateurs éligibles de gagner des

WALTHAM, Mass, Nov. 07, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies, today announced the Company’s participation at the following healthcare investor conferences: Guggenheim’s Inaugural Healthcare

UTRECHT, The Netherlands, Nov. 07, 2024 (GLOBE NEWSWIRE) — Today, ATNi launches the 5th edition of the Global Access to Nutrition Index, the largest yet, assessing the world’s 30 largest food and beverage manufacturers and over 52,000 products, representing 23% global market share. One in five deaths globally is associated